Abstract:OBJECTIVE To investigate the antibiotics resistance of clinical isolates from central-southern China in 2011 so as to provide evidence for the clinical medication.METHODS The antimicrobial susceptibility testing of the clinical isolates from 6 hospitals in the central-southern China was tested by Kirby-Bauer method or automated system,the results were determined according to CLSI,2011,and the statistical analysis was performed by WHONET5.6.RESULTS A total of 23 985 strains were isolated from 6 hospitals in central-southern China in 2011,with 69.3% of the gram-negative bacilli and 30.7% of the gram-positive cocci.The top five species of pathogens were Escherichia coli,Pseudomonas aeruginosa,Staphylococcus aureus,Acinetobacter baumannii and Klebsiella pneumonia.The detection rates of the MRSA and MRSCN were 54.3% and 75.6%,respectively.Less than 2.0% of the Enterococcus spp were resistant to vancomycin or teicoplanin.The isolation rates of ESBLs-producing E.coli,Klebsiella spp and P.mirabilis were 74.8%,54.6%,and 14.5%,respectively.The drug susceptibility rates of Enterobacteriaceae to carbapenems ranged between 90.3% and 100%.The drug resistance rates of A.baumannii to imipenem and meropenem were about 50.0%,and less than 30.0% of P.aeruginosa.The S.maltaphilia isolates were most susceptible to levofloxacin and minocycline,with the drug susceptibility rates higher than 80.0%,and less than 60.0% to ceftazidime and ticarcillin-clavulanic acid.The drug susceptibility rates of Burkholderia to meropenem and minocycline were higher than 70.0% and was the lowest to ticarcillinclavulanic acid(17.1%).The isolation rates of β-lactamase-producing H.influenzae was 44.8%,the drug susceptibility rates to all the antibiotics were higher than 70.0% except ampcillin and sulfamethoxazole / trimethoprim.CONCLUSION The gram-negative bacilli remain prevalent in the clinical isolates,and bacterial resistance rate is on the rise.The prevalence of ESBLs-producing Enterobacteriaceae isolates increase significantly.Great attention should be paid to the prevalence of vancomycin-resistant Enterococci,carbapenems-resistant Enterobacteriaceae and multi-drug resistant gram-negative bacilli.

Mohnarin of 2008: Surveillance Results of National Bacterial Drug Resistance

Surveillance of antibiotic resistance in clinical isolates from First Affiliated Hospital of Zhejiang University Medical College in 2009

Antimicrobial Resistance Surveillance Study in 2008 on the Nosocomial Enterobacteriaceae Strains Isolated from 15 Teaching Hospitals in China

Mohnarin Report of 2011 : Monitoring of Bacterial Resistance in Northwest China

Mohnarin Report of 2010 :Surveillance of Bacterial Resistance of Non-Icu Inpatients

Mohnarin Report of 2010 :Surveillance of Bacterial Resistance of Outpatient and Emergency Patients

Mohnarin report of 2011:monitoring of bacterial resistance of non-ICU inpatients

Mohnarin Report of 2010:Bacterial Resistance in Northwest China

Mohnarin Report of 2011 : Monitoring of Bacterial Resistance in Central-Southern China

Mohnarin Annual Report of 2009:Bacterial Drug Resistance Surveillance of Outpatients and Emergency Patients

Mohnarin Report of 2010:Surveillance of Resistance of Pathogens from Urine Specimens

Mohnarin Report of 2010:Monitoring of Bacterial Resistance in Intensive Care Units

Mohnarin Report of 2010:Bacterial Distribution and Resistance in North China

Mohnarin Report of 2010:Bacterial Composing and Resistance in Bloodstream Infections

Mohnarin Report of 2011: Monitoring of Bcterial Resistance Intensive Care Unit

Mohnarin Report of 2011:Distribution and Drug Resistance of the Bacteria Causing Blood Stream Infections

Mohnarin Report of 2011:Bacterial Distribution and Resistance in Northeast China

Ministry of Health National Antimicrobial Resistant Investigation Net annual report of 2010: bacterial drug resistance surveillance of outpatients

Mohnarin of 2009:Bacterial Distribution and Resistance Surveillance in Beijing

2008 Mohnarin Report:Bacterial Drug Resistance Surveillance of Emergency Outpatients

Mohnarin Report 2010:Surveillance of Antimicrobial Resistance of Clinical Isolates from Non-ICU Inpatients